Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
polydepsia • excessive thirst accompanied by temporary or prolonged dryness of the mouth • Causes of polydipsia • Increased thirst is often the reaction to fluid loss during exercise, or to eating salty or spicy foods • • • • It may be due to an organic lesion or have a psychological cause. Diabetes mellitus Diabetes insipidus Dehydration(Diarrhoe –Vomiting -Profuse sweating -Significant blood loss – decreased thirst sensation – cognitive impairment) • drug-induced polydipsia • diuretics, anticholinergic, salt, , megestrol acetate , mannitol, sorbitol may cause a polyuria and, secondarily, a polydipsia Loss of body fluids from the bloodstream into the tissues due to: burns – sepsis, or heart, liver, or kidney failure • Psychogenic polydipsia - compulsive water drinking associated with mental/psychiatric disorders The physiology of thirst • An important factor in the maintenance of fluid balance is the secretion of antidiuretic hormone (ADH). ADH, also known as vasopressin: – Is secreted by the hypothalamus when plasma osmolality increases. – Acts mainly on the distal renal tubule, where ADH binds to receptor sites and stimulates the reabsorption of water. • The physiological driving force is thus the maintenance of blood osmolality. • Sensory osmoreceptors in the brain stimulate cortical effector regions, principally in the anterior cingulate cortex , to trigger the sensation of thirst in response to a rise in blood osmolality.[This sensation usually starts at 280 mOsmol/kg. The intensity of thirst and the amount of water required are directly proportional to blood osmolality • • • • • • • Circulating angiotensin II is known to play a role. It is known that the area of the hypothalamus which releases angiotensin II is anatomically close to, and linked neuronally with, the area that releases ADH, so there is clearly a close connection between the two systems.[ angiotensin II binds to the angiotensin type 1 receptor, stimulating thirst oropharyngeal sensors quell the thirst desire before any changes in osmolality drinking water quenched thirst more rapidly than when the same amount of water was mixed with food (eg, in soup). Acute falls in blood pressure and/or blood volume will also stimulate thirst. 15% or more reduction in circulating blood volume is required for this effect. However, the effect of osmolality changes on thirst is more significant. the habit of drinking with meals (secondary drinking ) compensated by renal excretion With increasing age the thirst stimulus becomes blunted (hypodipsia) with a reduction in primary drinking. This is usually compensated for by secondary drinking.However, it may be a contributory factor in causing dehydration • Diabetes mellitus in which an excessive concentration of glucose in the blood osmotically pulls intracellular fl uid into the bloodstream and increases the excretion of fluid via increased urination, which leads to hypovolemia and thirst. • In diabetes insipidus the deficiency of the pituitary ant idiuretic hormone results in excretion of copious amou nts of dilute urine, reduced fluid volume in the body, and polydipsia. In nephrogenic diabetes insipi dus there is also copious excretion of urine with conse quent polydipsia Diabetes insipidus • hyposecretion of, or insensitivity to the effects of (ADH), also known as arginine vasopressin (AVP). ADH is synthesised in the hypothalamus and transported as neurosecretory vesicles to the posterior pituitary. • There it is released into the circulation, governed by plasma osmolality. Its deficiency or failure to act causes an inability to concentrate urine in the distal renal tubules, leading to the passage of copious volumes of dilute urine. Usually the sufferer passes >3 litres/24 hours of low osmolality (<300 mOsmol/kg) urine. There are two major forms of DI: • • • Cranial DI: decreased secretion of ADH. This is usually due to disease of the hypothalamus Posterior pituitary disease tends not to cause DI, as secretion continues in the hypothalamus. – Causes: – idiopathic – Brain Tumours , craniopharyngioma, hypothalamic metastases (especially breast carcinoma), hypothalamic glioma, large pituitary tumours with suprasellar extension, lymphoma – Intracranial surgery – Head injury. – Granulomata - sarcoidosis, tuberculosis (TB), – Infections - encephalitis, meningitis, cerebral abscess – Vascular disorders - haemorrhage/thrombosis, aneurysms, , Sheehan's syndrome (postpartum pituitary necrosis). – Post-radiotherapy. Inherited: Autosomal recessive combination of DI, diabetes mellitus, optic atrophy, deafness (DIDMOAD) – Autosomal dominant mutations of vasopressin gene Nephrogenic DI • decreased ability to concentrate urine because of resistance to ADH in the kidney. • Acquired nephrogenic DI: – – – – – Idiopathic. Hypokalaemia. Hypercalcaemia. Chronic kidney disease. Renal tubular acidosis. • obstructive uropathy • Congenital/genetic nephrogenic DI: • X-linked mutation ADH-receptor gene. Presentation • • • • • • • • • Symptoms vague and insidious, marked polyuria. variable between patients (3-20 litres). Polydipsia. Nocturia occurring several times per night is common, particularly in older adults. urinary incontinence Signs signs of dehydration (confusion –dizziness – sunken eyes rapid heart rate –low blood pressure )and the bladder can be grossly enlarged and palpable 24-hour urinary collection will show urine volume >3 litres/24 hours Investigations • plasma glucose, and plasma and urine osmolality . • Fluid deprivation test with response to desmopressin. The patient is deprived of fluids for up to eight hours following which desmopressin (DDAVP®) 2 micrograms (IM) is given. See table below for interpretation of the results. • A therapeutic trial of low-dose desmopressin is another option, with careful monitoring of plasma osmolality or serum sodium. Cranial DI patients improve, and those with nephrogenic DI are unaffected. Those with PP develop hyponatraemia and may stop drinking. • MRI of the pituitary, hypothalamus and surrounding tissues • Renal tract ultrasound or intravenous pyelogram (IVP) may be used to assess for obstructive complications caused by the high urinary back-pressure. Classification of causes of diabetes insipidus on basis of water deprivation and DDAVP® response Urine osmolality after fluid deprivation (mOsm/kg) Urine osmolality after DDAVP® (mOsm/kg) Likely diagnosis <300 >800 CDI <300 <300 NDI >800 >800 Primary/psychogenic polydipsia Interpretation of results • Renal function tests and glucose levels should be assessed to rule out chronic kidney disease and diabetes mellitus. A urine specific gravity of 1.005 or less and a urine osmolality less than 200 mOsmol/kg are highly suggestive of diabetes insipidus. Random plasma osmolality is usually greater than 287 mOsmol/kg. • In normal individuals, the urine osmolality is 2-4 times greater than the plasma osmolality. Administration of vasopressin results only in a small increase in urine osmolality (less than 9%). It takes between 4-18 hours to achieve maximal concentration of urine. • In central diabetes insipidus (due to decreased production of ADH), there is an excessive increase in plasma osmolality but not in urine osmolality. Administration of vasopressin results in an increase in urine osmolality of 50% or more. ADH levels are minimal. • In nephrogenic diabetes insipidus (due to resistance of renal tissue to the action of ADH), ADH levels are normal to elevated and the kidney fails to respond to exogenous ADH during the water deprivation test. • In psychogenic polydipsia, water deprivation will show the same changes as normal individuals, There is no response to exogenous ADH. Management • Cranial DI • As the primary problem is a hormone deficiency, physiological replacement with desmopressin is usually effective. This can be given orally, intranasally or parenterally. • Mild cases of DI (urine output 3-4 litres/24 hrs) can be managed by ingestion of water to quench thirst. • It is essential to avoid chronic overdosage with desmopressin, which will cause hyponatraemia. • Long-term management: – Because of the risk of hyponatraemia, (1- to 3-monthly) measurements of serum sodium are advised. – Some endocrinologists recommend missing desmopressin treatment one day each week to avoid the development of hyponatraemia. Nephrogenic DI • If daily urine volume is <4 litres/24 hrs and the patient is not suffering from severe dehydration then definitive therapy is not always necessary. • Correct any metabolic abnormality. • Stop any drugs that may be causing the problem. • High-dose DDAVP® may be used with success in mild to moderate cases of nephrogenic DI.. . Complications • DDAVP® can worsen myocardial ischaemia in susceptible patients • Patients with genetic causes of nephrogenic DI are prone to bladder dysfunction and hydroureter/hydronephrosis if the condition is undiagnosed or untreated for an appreciable period of time • Patients with genetic causes or severe nephrogenic DI may need, intermittent catheterisation to reduce urinary tract backpressure complications Prognosis • Death is rare, the elderly with acute illness or surgery are more at risk of severe dehydration, hypernatraemia, fever, cardiovascular collapse and death • Patients with inborn errors are more likely to suffer complications as the underlying cause cannot be removed. Psychogenic Polydipsia (Exessive Fluid Seeking Behaviour) • • • • • • • • • • • • type of polydipsia exhibited by patients with mental illness Psychogenic polydipsia, is a condition of psychological rather than physiologic origin. When the intake of water exceeds the body’s ability to manage it, imbalance ensues Psychogenic polydipsia is a serious disorder that often leads to institutionalization. It should be taken very seriously and can be life-threatening, as serum sodium is diluted to an extent that seizures and cardiac arrest can occur. The urine produced by these clients will have a low electrolyte concentration, and it will be produced in large quantities (i.e., polyuria). close monitoring by staff is necessary to control fluid intake. the kidneys will be unable to deal with fluid overload and a more serious symptom of selfinduced water intoxication (i.e.,SIWI). Individuals diagnosed with ”psychogenic polydipsia” — of which 80% are diagnosed with schizophrenia have a fluid intake that is usually 4 – 10L/day, some drink up to 22L/day! Hyponatremia 25% of polydipsia patients have acute development of hyponatremia Behavioral management programs should be mandatory.Psychosocial rehabilitation (PSR) programs for individuals diagnosed with psychogenic polydipsia, Clozapine is an atypical antipsychotic medication, antipsychotics such as risperidone and angiotensin-II receptor antagonists, such as irbesartan. Complications of polydepsia • A distinction between organic and psychogenic polydipsia. • In the former, once the underlying condition is treated, complications from the polydipsia are few. This is because homeostasis tends to be preserved. • In psychogenic polydipsia, water continues to be drunk in excess irrespective of the osmotic status of plasma and urine. This can result in water intoxication with subsequent cardiac failure, and urinary tract abnormalities Management • The management of polydipsia depends on the underlying cause Thank you